SILVER SPRING, MD (updated, corrected) — A massive study of Medicare patients at risk of stroke secondary to atrial fibrillation (AF) has found no signal of increased MI risk with dabigatran (Pradaxa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback